Compare VTRS & RBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VTRS | RBC |
|---|---|---|
| Founded | 1961 | 1919 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.0B | 12.6B |
| IPO Year | N/A | 2005 |
| Metric | VTRS | RBC |
|---|---|---|
| Price | $10.96 | $444.26 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 6 | 6 |
| Target Price | $11.17 | ★ $441.17 |
| AVG Volume (30 Days) | ★ 7.8M | 165.1K |
| Earning Date | 11-06-2025 | 10-31-2025 |
| Dividend Yield | ★ 4.39% | N/A |
| EPS Growth | N/A | ★ 19.54 |
| EPS | N/A | ★ 8.20 |
| Revenue | ★ $14,124,400,000.00 | $1,723,400,000.00 |
| Revenue This Year | N/A | $14.65 |
| Revenue Next Year | $1.16 | $10.87 |
| P/E Ratio | ★ N/A | $54.08 |
| Revenue Growth | N/A | ★ 8.27 |
| 52 Week Low | $6.85 | $290.56 |
| 52 Week High | $13.13 | $449.60 |
| Indicator | VTRS | RBC |
|---|---|---|
| Relative Strength Index (RSI) | 60.39 | 63.56 |
| Support Level | $10.67 | $431.72 |
| Resistance Level | $10.93 | $448.31 |
| Average True Range (ATR) | 0.24 | 10.45 |
| MACD | 0.01 | -0.71 |
| Stochastic Oscillator | 90.23 | 79.84 |
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.
RBC Bearings Inc is an international manufacturer and marketer of engineered precision bearings, components, and essential systems for the industrial, defense, and aerospace industries. The offering includes plain bearings, roller bearings, ball bearings, and engineered products. The company has two reportable segments: Industrial, which derives maximum revenue, and Aerospace/Defense. The Aerospace/Defense segment represents the end markets for the company's engineered bearings and precision components used in commercial aerospace, defense aerospace, and sea and ground defense applications; and the Industrial segment represents the end markets for its products used in various industrial applications. Geographically, the company generates a majority of its revenue from the United States.